21. Not until the regulatory committee meticulously reviewed the newly submitted clinical trial data
______ the pharmaceutical conglomerate to resume the production of its controversial medical device.
(A) they allowed
(B) did they allow
(C) the committee allowed
(D) was allowed
答案:登入後查看
統計: 尚無統計資料
統計: 尚無統計資料